Global Anti-Asthmatics and COPD Drugs Market Forecast to Reach $49,384.3 million in 2020 Due to Increased Demand in the Treatment of COVID-19 Patients
DUBLIN, June 30, 2020 /PRNewswire/ -- The "Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The "Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth" report provides strategists, marketers and senior management with the critical information they need to assess the demand for anti-asthmatics and COPD drugs market which play a critical role in the treatment of patients with Covid 19.
This report describes and evaluates the global anti-asthmatics and COPD drugs market. It covers two five-year periods, one three-year period, and one six-year period including, 2015 to 2019, termed the historic period, and 2019 to 2023 forecast period, 2023-2025 forecast period and 2025 -2030 the forecast period.
The global anti-asthmatics and COPD drugs market reached a value of nearly $40,162.1 million in 2019, having grown at a compound annual growth rate (CAGR) of 4.4% since 2015. The global anti-asthmatics and COPD drugs market is expected to grow from $40,162.1 million in 2019 to about $49,384.3 million in 2020 due to an increase in demand for the use of anti-asthmatics and COPD drugs in the treatment of Covid-19 patients. The global anti-asthmatics and COPD drugs market is expected to grow at a CAGR of 4.1% to nearly $47,176.2 million by 2023. Also, the market is expected to grow to $51,164.1 million in 2025 at a CAGR of 4.1% and to $63,579.9 million in 2030 at a CAGR of 4.4%.
Going forward, the increased popularity of e-cigarettes/vaping, rising obesity levels, technology, large pool of undiagnosed population, use of anti-asthmatics and COPD drugs to treat COVID-19 patients, and increasing consumption of fats are expected to drive the market. Factors that could hinder the growth of the anti-asthmatics and COPD drugs market in the future include side effects associated with respiratory drugs, reduction in free trade, and stringent regulations.
Key Topics Covered:
1. Anti-Asthmatics And COPD Drugs Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
7. Anti-Asthmatics And COPD Drugs Market Characteristics
8. Anti-Asthmatics And COPD Drugs Market, Supply Chain Analysis
9. Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis
10. Anti-Asthmatics And COPD Drugs Market, Top 10 Leading Drugs Sales
11. Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs
12. Anti-Asthmatics And COPD Drugs Market, Customer Information
13. Impact of COVID-19 On The Anti-Asthmatics And COPD Drugs Market
14. Anti-Asthmatics And COPD Drugs Market Regulatory Landscape
15. Anti-Asthmatics And COPD Drugs Market Trends And Strategies
16. Asthma And COPD Prevalence Overview
17. Global Anti-Asthmatics And COPD Drugs Market Size And Growth
18. Anti-Asthmatics And COPD Drugs Market, Regional And Country Analysis
19. Global Anti-Asthmatics And COPD Drugs Market Segmentation
20. Asia-Pacific Anti-Asthmatics And COPD Drugs Market
21. Western Europe Anti-Asthmatics And COPD Drugs Market
22. Eastern Europe Anti-Asthmatics And COPD Drugs Market
23. North America Anti-Asthmatics And COPD Drugs Market
24. South America Anti-Asthmatics And COPD Drugs Market
25. Middle East Anti-Asthmatics And COPD Drugs Market
26. Africa Anti-Asthmatics And COPD Drugs Market
27. Global Anti-Asthmatics And COPD Drugs Market Competitive Landscape
27.1. Company Profiles
27.2. GlaxoSmithKline plc.
27.3. AstraZeneca plc.
27.4. Boehringer-Ingelheim GmbH
27.5. F. Hoffmann-La Roche Ltd
27.6. Novartis AG
28. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market
29. Market Background: Respiratory Diseases Drugs Market
30. Anti-Asthmatics And COPD Drugs Market Opportunities And Strategies
31. Global Anti-Asthmatics And COPD Drugs Market Recommendations
32. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/wau2ab
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
